This is an amended filing
GeneOne Life Science, Inc. Record date for extraordinary shareholders meeting changed to Dec 18 (amended filing)
AI summary · Not investment advice
JVM-related filing: Genexine-type name omitted; the company set Dec 18 as the date to decide which shareholders can join its extraordinary shareholders meeting, changed from Oct 28.
Key facts
- Record date
- Dec 18, 2026
- Reason
- Determination of shareholders entitled to rights at the 2nd Extraordinary General Meeting of Shareholders for the 51st fiscal term
Commentary
AI commentary · Not investment advice
What happened
Genexine set a new record date for deciding which shareholders can take part in its 51st-term 2nd extraordinary shareholders' meeting.
In the company's terms
The date had earlier been set for October 28. This filing changes it. The reason is to confirm the shareholders entitled to vote at the meeting.
What changes for shareholders
The new record date is December 18, 2026, and it is confirmed. Shareholders on the register as of that day get the right to take part in the meeting. The materials do not give the date of the meeting itself.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G